PDS Biotechnology (PDSB) Misses Q3 EPS by 4c; Reports Cash and Cash Equivalents of $69.7M
PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.